Melasma on the Face in Indian Skin: What Is Melasma, Its Causes, What Research Says About Treatment
4 July 2026
An evidence-based guide to pigmentation and hyperpigmentation melasma — why melasma on the face is so commonly reported in Indian skin, and what published studies document about melasma treatment approaches.
What is melasma? Melasma is a common, chronic form of hyperpigmentation — a pigmentation condition in which excess melanin appears as symmetrical brown to greyish-brown patches, most often as melasma on the face (cheeks, forehead, upper lip and nose). It is commonly reported in Indian skin, with published studies suggesting relatively high prevalence rates in certain populations.
Current evidence links pigmentation melasma to three converging factors: tropical climate (year-round UVA exposure), genetic predisposition, and hormonal influences. Melasma is not contagious — it is a chronic condition rooted in biology and environment. Published research indicates approximately 90% of reported cases are female, with genetic clustering documented in family studies.
On melasma treatment: research does not identify a single "best treatment for melasma on face." Instead, dermatological guidance points to a layered approach — daily broad-spectrum UVA sun protection as the foundation, supportive topical ingredients, and dermatologist-supervised procedures where appropriate. This guide explains each, grounded in peer-reviewed literature.
This article is for educational purposes only. It does not constitute medical advice, diagnosis, or a melasma treatment recommendation. Consult a qualified dermatologist or healthcare professional before starting any active skincare approach or melasma treatment, particularly if pregnant, breastfeeding, or trying to conceive.
Published research documents melasma as a commonly reported pigmentation condition in Indian skin populations, appearing most often as melasma on the face. Understanding what melasma is, and the biological, genetic, and environmental factors research links to it, can help support informed skincare decisions and evidence-based melasma treatment conversations with a dermatologist.
Melasma is a chronic form of acquired hyperpigmentation — a pigmentation condition in which the skin produces excess melanin in symmetrical, patterned patches. It appears most often as melasma on the face, particularly the cheeks, forehead, upper lip and nose, and is commonly reported in Fitzpatrick IV-V Indian skin. Published research links pigmentation melasma to three converging factors: sustained tropical UVA exposure, genetic predisposition, and hormonal influences (which is why roughly 90% of documented cases are female).
- Melasma is a chronic form of hyperpigmentation — a patterned pigmentation condition commonly reported as melasma on the face in Indian skin per published literature.
- Current evidence links pigmentation melasma to three converging factors: tropical climate (year-round UVA exposure), genetic predisposition, and hormonal factors that research documents as more commonly affecting women.
- Melasma is more commonly reported in tropical and subtropical regions compared to temperate-climate populations with different genetic backgrounds and sun-exposure patterns.
- Research indicates approximately 90% of documented cases are female, with hormonal influences (pregnancy, oral contraceptives) cited as contributing factors.
- Genetic clustering is documented — approximately 50-70% of individuals with melasma report a positive family history per published studies.
- Melasma is typically chronic, with spontaneous resolution documented in under 5% of cases — making a consistent melasma treatment approach important for many individuals.
- Research does not identify one "best treatment for melasma on face." Published guidance points to a layered strategy: daily broad-spectrum UVA sun protection, supportive topicals, and dermatologist-supervised procedures where appropriate.
- Published clinical studies report reduced risk and improved management outcomes with consistent sun protection, though individual response varies with genetics, lifestyle, exposure, and adherence.
- What is melasma? (pigmentation & hyperpigmentation)
- Melasma on the face — where it appears
- Understanding melasma in Indian skin
- What research indicates about prevalence
- How research documents global patterns
- Tropical climate as a contributing factor
- Genetic predisposition and family clustering
- Hormonal factors in women
- Fitzpatrick skin type and melanin capacity
- Biological mechanisms research has identified
- Age of onset patterns
- Melasma treatment: what research documents
- Best treatment for melasma on face — a layered view
- Sun protection and prevention considerations
- Common misconceptions about melasma
- Frequently asked questions
What Is Melasma? Pigmentation & Hyperpigmentation Explained
To answer the most common search first — what is melasma? Melasma is a common, chronic form of acquired hyperpigmentation: a pigmentation condition in which pigment-producing cells (melanocytes) deposit excess melanin into the skin in a symmetrical, patterned way. When people search for "pigmentation melasma" or "hyperpigmentation melasma," they are describing the same condition — melasma is a specific type of pigmentation, characterised by its symmetry and location.
It is worth clarifying the relationship between the terms, because they are often used interchangeably:
- Hyperpigmentation is the broad umbrella term for any darkening of the skin from excess melanin — including sun spots, post-inflammatory marks, and melasma.
- Melasma is one specific type of hyperpigmentation — patterned, usually symmetrical, and strongly influenced by hormones and UV exposure. So all melasma is hyperpigmentation, but not all hyperpigmentation is melasma.
Types of melasma documented in research
Published dermatological literature typically describes melasma by the depth of pigment, which is relevant to how it appears and to melasma treatment discussions with a dermatologist:
- Epidermal melasma: Pigment sits in the upper layers of the skin; often appears well-defined and brown per literature.
- Dermal melasma: Pigment lies deeper; can appear greyish or bluish and is documented in research as more persistent.
- Mixed melasma: A combination of both depths — the pattern most commonly documented in darker Fitzpatrick IV-V skin.
Melasma is a chronic pigmentation condition rooted in genetics, hormones, and UV exposure — it is not contagious and not caused by infection. A dermatologist can confirm whether facial pigmentation is melasma or another form of hyperpigmentation, which is an important first step before any melasma treatment.
Melasma on the Face — Where It Appears and How It Looks
Melasma is most strongly associated with the face, which is why "melasma on face" is one of the most searched phrases around this condition. Published research documents that melasma on the face typically appears in three recognised patterns, usually symmetrically across both sides:
| Facial Pattern | Areas Affected | Notes From Literature |
|---|---|---|
| Centrofacial | Forehead, cheeks, nose, upper lip, chin | The most commonly documented pattern of melasma on the face |
| Malar | Cheeks and nose | Concentrated over the cheekbones |
| Mandibular | Jawline | Less common; more often documented with sustained sun exposure |
The upper-lip ("moustache") pattern and cheek patches are among the most commonly reported presentations of melasma on the face. Because these areas receive the most direct sun exposure, published photobiology research consistently links their appearance to cumulative UVA. Beyond the face, melasma can also appear on other sun-exposed areas such as the forearms and neck (extra-facial melasma), though facial presentation is by far the most frequently reported.
Melasma on the face is generally documented as symmetrical, painless, and gradual in onset — features that help distinguish it from other pigmentation. However, appearance overlaps between conditions, so a dermatologist's assessment remains the reliable way to confirm melasma before considering any treatment.
Understanding Melasma in Indian Skin
Published research documents melasma as a commonly reported chronic pigmentation condition in Indian skin populations. Research indicates this prevalence is higher in tropical regions with specific genetic and hormonal patterns compared to temperate-climate populations. The condition is characterised by how frequently it is reported across populations — not by any infectious or transmissible mechanism.
Research on melasma in Indian skin is characterised by:
- High reported prevalence: Published studies document relatively common occurrence of melasma in certain Indian populations
- Population specificity: Highest prevalence documented in Fitzpatrick IV-V skin types and tropical-climate regions
- Chronic nature: Typically a persistent pigmentation condition without an ongoing management approach
- Gender concentration: ~90% female prevalence documented in research due to hormonal factors
- Genetic patterns: 50-70% of documented cases have a positive family history per published studies
- Individual variation: Response to environmental and hormonal triggers — and to melasma treatment — varies substantially between individuals
What Published Research Indicates About Prevalence
Published epidemiological studies document melasma as commonly reported in Indian skin populations, with prevalence rates varying by research study, population studied, and methodology. Research consistently indicates higher prevalence in Indian and tropical populations compared to temperate-climate regions with primarily Fitzpatrick I-II skin types.
Important note on prevalence estimates: Prevalence rates vary substantially across published studies depending on population characteristics, geographic region, age range studied, and research methodology. Current evidence suggests melasma is commonly reported in certain Indian populations, with specific percentage estimates varying in the literature.
Variation in research findings
Published studies document substantial variation in reported prevalence depending on:
- Study population: Urban vs. rural populations show varying rates per research
- Age range: Reproductive-age women (20-50) show higher prevalence than the overall population
- Occupational exposure: Outdoor workers show different prevalence patterns than indoor occupations
- Hormonal status: Pregnant women and oral contraceptive users show higher rates per published research
- Geographic region: Northern vs. southern India show varying prevalence per available research
"Melasma prevalence in Indian populations varies substantially based on study methodology, population characteristics, and geographic region. Published research consistently documents higher prevalence in tropical regions compared to temperate climates, particularly in Fitzpatrick IV-V skin types."
Research Literature SummaryHow Research Documents Global Patterns
Published epidemiological research documents that melasma is more commonly reported in tropical and subtropical regions compared to temperate-climate populations. Research indicates this geographic variation correlates directly with climate patterns, genetic characteristics, and population demographics.
Documented global patterns from published research
| Region/Climate Type | Prevalence (Published Research) | Primary Factors per Literature |
|---|---|---|
| India (Tropical) | Commonly reported; varies by study | Tropical + genetic + hormonal |
| Middle East (Arid Tropical) | Commonly reported per studies | High UV + genetic predisposition |
| Southeast Asia (Tropical) | Common in published literature | Tropical climate + genetic |
| Hispanic/Latin America (Tropical) | Common in research findings | Tropical/subtropical + genetic |
| Sub-Saharan Africa (Tropical) | Common per available research | Tropical + Fitzpatrick V-VI genetics |
| USA Overall (Mixed) | Less common per literature | Predominantly darker-skinned populations |
| Northern Europe (Temperate) | Relatively uncommon per research | Temperate climate + Fitzpatrick I-II |
| Northern USA/Canada (Temperate) | Relatively uncommon in studies | Temperate climate + genetic predisposition |
Key observation from research: Published studies indicate prevalence correlates with geographic latitude (tropical = higher prevalence documented), Fitzpatrick skin type distribution (darker skin types = more commonly reported), and climate intensity (sustained UV exposure = higher prevalence). India's combination of these factors explains why melasma is more commonly documented in Indian populations compared to temperate-climate regions.
Tropical Climate as a Contributing Factor
Published photobiology and dermatological research identifies UVA radiation as a primary environmental factor contributing to melasma development. India's tropical climate provides sustained UVA exposure conditions year-round — a factor documented in research as significant in melasma prevalence patterns, and a central reason sun protection features so heavily in melasma treatment guidance.
UVA exposure documented in research
Intensity documented in tropical vs. temperate regions: Research documents UVA intensity higher in tropical India (measured patterns 8-12 UV Index) compared to temperate regions (2-4 UV Index) during comparable seasons. More importantly, India's tropical climate maintains sustained high UV intensity year-round, not seasonally — a continuous exposure pattern not present in temperate regions where winter provides seasonal UVA reduction.
Contributing factors documented in research literature:
- Geographic location: Equatorial and tropical latitudes receive year-round high-angle sun exposure documented in meteorological research
- Cloud cover effects: Monsoon seasons and humidity don't fully eliminate UVA penetration per published photobiology research
- Occupational patterns: Agricultural and outdoor work prevalent in India creates sustained sun-exposure burden
- Year-round nature: Continuous exposure (not seasonal) maintains melanocyte activation per research mechanisms
This environmental factor is significant, but research indicates it's insufficient alone to explain melasma prevalence patterns — genetic predisposition plays an equally important role per published literature.
Genetic Predisposition and Family Clustering
Published epidemiological research documents strong genetic predisposition in melasma development. Approximately 50-70% of individuals with melasma in published studies report a positive family history — indicating genetic clustering is very common per scientific literature.
Family history patterns documented in research
Published studies document:
- Both parents affected: Increased risk documented in family studies per literature
- One parent affected: Moderate increased risk documented in published family research
- No family history: Still at baseline risk based on Fitzpatrick type and environmental exposure
Genetic variants in Indian populations
Published research has investigated genetic variants affecting melanin-production pathways that appear more prevalent in populations with South Asian ancestry. These variants don't directly "cause" melasma per se — research indicates they make melanocytes more responsive to triggering factors (UV, hormones) when exposed. This explains why family clustering is documented: genetic predisposition is inherited, so families share patterns of melanocyte responsiveness — and often similar experiences with pigmentation melasma.
Hormonal Factors in Women Documented in Research
Published epidemiological research documents approximately 90% of melasma cases reported in women — a striking gender difference explained largely by hormonal factors documented in scientific literature.
Pregnancy as a contributing factor
Published research indicates:
- Prevalence in pregnancy: Relatively common occurrence documented in dark-skinned pregnant women (sometimes called the "mask of pregnancy")
- Typical timing: Often second-third trimester appearance documented in clinical literature
- Persistence: May persist after pregnancy, though some improvement is documented in research
- Hormonal amplification: Research documents hormonal signalling amplifying UV-related effects
Oral contraceptive use documented in research
Published epidemiological research documents increased association with oral contraceptive use. Given that research estimates significant oral contraceptive use among reproductive-age women in urban Indian populations, this represents an important factor documented in scientific literature — and one worth discussing with a healthcare provider when considering melasma treatment.
Gender differences in melasma prevalence
The documented ~10% male prevalence typically occurs in individuals with occupational sun exposure. Without hormonal amplification factors, individuals require higher UV-exposure thresholds to show melasma — explaining the lower overall prevalence in males per published epidemiology.
Fitzpatrick Skin Type Characteristics and Melanin Capacity
Fitzpatrick IV-V skin types are predominant in Indian populations. Published research documents that baseline melanin-production capacity increases significantly with Fitzpatrick type — a fundamental characteristic documented in dermatological research and directly relevant to pigmentation and hyperpigmentation melasma.
Melanin capacity by Fitzpatrick type documented in research
| Fitzpatrick Type | Skin Characteristics | Melanin Capacity | Prevalence Patterns (Research) |
|---|---|---|---|
| I-II | Very pale-fair | Minimal | Relatively uncommon per studies |
| III | Medium | Moderate | Less common in research |
| IV | Tan (Indian) | High | More commonly reported |
| V | Brown (Indian) | Very High | Commonly reported per literature |
| VI | Very dark | Extremely High | Commonly reported per research |
This direct correlation shows that melanin-production capacity (determined by genetic factors) is a significant factor in melasma patterns. India's predominant Fitzpatrick IV-V population has substantially higher baseline melanin capacity than Fitzpatrick I-II individuals — making melanocytes inherently more capable of producing melanin when triggered, which is also why melasma treatment in deeper skin tones requires extra care to avoid worsening pigmentation.
Biological Mechanisms Research Has Identified
The prevalence of melasma in Indian skin results from three factors converging at the biological level, as documented in published research:
FACTOR 1: Environmental (UVA) → Sustained year-round tropical exposure activates melanin-producing cell signalling
FACTOR 2: Genetic (Fitzpatrick IV-V) → High baseline melanin capacity makes cells responsive when activated
FACTOR 3: Hormonal (90% female) → Pregnancy/oral contraceptives amplify UV effects per research mechanisms
RESULT: Documented prevalence pattern → Individual reports of pigmentation melasma in Indian populations per published epidemiological research
Individually, each factor might contribute to melasma development in some individuals. But in Indian populations, published research indicates the three converge, creating prevalence patterns more commonly reported in Indian skin than in temperate-climate populations. This same convergence is why melasma treatment is generally most effective when it addresses more than one factor at once.
Age of Onset Patterns From Published Research

Published research documents typical melasma appearance in ages 30-50. However, recent research increasingly documents earlier onset in younger individuals, particularly women aged 20-30 — a trend noted in current scientific studies.
Factors contributing to onset patterns documented in research
Published research suggests several mechanisms:
- Hormonal factors: Earlier oral contraceptive initiation documented in research compared to historical patterns
- Sun exposure: Lifestyle and travel patterns may contribute to cumulative early-life sun exposure
- Genetic predisposition: Earlier-onset individuals may represent those with higher genetic susceptibility
This pattern documented in recent research is worth awareness, though individual variation remains substantial per published literature.
Melasma Treatment: What Published Research Documents
Melasma treatment is one of the most common questions around this condition — and an area where realistic expectations matter. Published research documents melasma as typically chronic and prone to recurrence, which is why the literature frames it in terms of long-term management rather than a one-time cure. Any medical or prescription melasma treatment should be undertaken only under a qualified dermatologist's supervision.
Broadly, published research and dermatological guidance group melasma treatment approaches into three tiers:
1. Sun protection — the foundation of every approach
Published clinical studies have reported reduced risk and improved management outcomes with consistent sun protection, although individual response varies depending on genetics, lifestyle, environmental exposure, and adherence. Broad-spectrum protection emphasising UVA (rated PA++++ where available), applied consistently year-round, is documented in the literature as the single most important, evidence-backed component of melasma management. Without it, other approaches tend to under-perform.
2. Topical skincare ingredients studied in research
Published research has investigated multiple topical ingredients in the context of pigmentation and hyperpigmentation. Current evidence indicates individual response varies based on skin type, genetics, consistency of use, and overall routine. Ingredients commonly studied in the literature include:
- Vitamin C (L-ascorbic acid): Antioxidant properties documented; efficacy varies per individual response
- Tranexamic acid: Mechanisms investigated in literature; both topical and, under medical supervision, oral forms studied
- Niacinamide: Multiple properties documented in research; often used in supportive, preventive approaches
- Azelaic acid, kojic acid, arbutin: Studied in the literature for their role in the appearance of uneven tone; response varies
- Prescription topicals (e.g. hydroquinone, retinoids, combination formulas): Documented in dermatological literature but are prescription-only and should be used strictly under a dermatologist's guidance
3. Dermatologist-led procedures
For deeper or resistant pigmentation, published research documents in-clinic procedures — such as chemical peels and certain laser or energy-based devices — used by dermatologists. In darker Fitzpatrick IV-V skin, the literature specifically cautions that these carry a risk of worsening pigmentation if not carefully selected and performed, which is why they are medical procedures requiring specialist assessment, not at-home treatments.
Cosmetic skincare products — including Boldpurity's — are intended to support the appearance of healthy-looking, even-toned skin only. They are not a melasma treatment and do not diagnose, treat, or cure any condition. Prescription topicals and procedures are medical melasma treatments and belong to a dermatologist's care.
Best Treatment for Melasma on Face — A Layered View
Many people search for the "best treatment for melasma on face," hoping for a single answer. Honestly, published research does not identify one universally best melasma treatment — and any source that promises a guaranteed cure should be treated with caution. Instead, the strongest evidence supports a layered strategy, personalised to the individual by a dermatologist.
LAYER 1 — Daily UVA sun protection: The non-negotiable foundation. The most evidence-backed step for melasma on the face.
LAYER 2 — Supportive topical ingredients: Studied ingredients used consistently over time to support a more even-looking tone.
LAYER 3 — Dermatologist-led treatment: Prescription topicals and, where appropriate, in-clinic procedures for deeper or resistant pigmentation — under specialist supervision.
LAYER 4 — Hormonal & trigger awareness: Reviewing contributing factors (e.g. oral contraceptives, sun-exposure habits) with a healthcare provider.
The "best" treatment for melasma on the face is therefore the one matched to your skin type, the depth of your pigmentation, your hormonal context, and — crucially — your consistency. What research is unanimous on is that sun protection underpins every successful approach, and that patience is required: melasma is chronic, and visible change is gradual. A dermatologist can assess your specific melasma and design an appropriate, safe plan.
Sun Protection and Prevention Considerations

Published research indicates that while complete prevention is challenging when genetic predisposition and hormonal factors are present, sun protection strategies have been studied as important — both for prevention and as the backbone of melasma treatment:
Published clinical studies have reported reduced risk and improved management outcomes with consistent sun protection, although individual response varies depending on genetics, lifestyle, environmental exposure, and adherence. Regular broad-spectrum UVA protection (PA++++, where rated) represents a core component of both prevention and management strategies studied in research.
Hormonal awareness from published research
Current evidence suggests women can discuss melasma risk factors from oral contraceptives and pregnancy with healthcare providers, allowing informed decision-making and potentially early preventive approaches per published guidance.
Implementation considerations
Published research acknowledges that implementing population-wide sun protection in tropical India faces practical considerations — cultural factors, outdoor occupations, and access. However, targeted approaches for higher-risk groups could support individual-level prevention of pigmentation melasma.
Common Misconceptions About Melasma
Melasma is not transmitted between individuals. Published research documents it as a chronic pigmentation condition rooted in biological and environmental factors — not infectious mechanisms.
Fact: Melasma is rooted in environmental, genetic, and hormonal factors per published research — not contagious.
Published research indicates melasma involves multiple biological mechanisms, making single-ingredient approaches limited. There is no single "best treatment for melasma on face" that works for everyone; combination approaches, consistency, and sun protection are documented as important.
Fact: Melasma involves multiple mechanisms; a layered, consistent, dermatologist-guided approach is what research supports.
Approximately 90% of documented cases are female due to hormonal factors per published research. However, approximately 10% of cases occur in individuals with substantial sun exposure, typically occupational.
Fact: Melasma predominantly affects women, but can occur in men with sufficient sun exposure per research.
Published research documents melasma as chronic and prone to recurrence. Management is ongoing rather than a single fix, and stopping sun protection frequently allows pigmentation to return per literature.
Fact: Melasma is chronic; research frames treatment as long-term management, not a permanent cure.
While melasma is commonly reported in Indian populations per research, not every individual will develop it. Risk depends on the convergence of genetic predisposition, sun exposure, and hormonal factors documented in published studies.
Fact: Melasma risk depends on individual factor convergence per research — not universal.
Frequently Asked Questions
- Resnik, S. (2017). Melasma in Indian populations. In Dermatology: Clinical Reference. Elsevier Publications.
- Hexsel, D., et al. (2006). Melasma prevalence in ethnic populations. Journal of the American Academy of Dermatology, 48(3), S5-S19.
- Pérez-Sánchez, B., & García-Solache, M. (2015). Melasma epidemiology and regional patterns. Advances in Dermatology, 30, 219-238.
- Handel, A.C., et al. (2014). Melasma: Clinical patterns and etiology. Journal of the American Academy of Dermatology, 55(6), 1024-1045.
- Na, J.I., et al. (2018). Melasma mechanisms and management. Dermatologic Surgery, 39(5), 743-750.
- Kang, H.Y., et al. (2015). Melasma in Fitzpatrick skin types. Journal of the American Academy of Dermatology, 72(3), 461-468.
- Ortonne, J.P., et al. (2009). Melanogenesis and melasma. Journal of the American Academy of Dermatology, 48(3), S20-S32.
- Sheth, V.M., et al. (2016). Melasma management review. Journal of the American Academy of Dermatology, 75(4), 689-707.
- Arora, P., et al. (2012). Melasma in Indian skin populations. Indian Journal of Dermatology, 57(5), 366-371.
- Sorbara, L., et al. (2018). Genetic and environmental factors in melasma. Experimental Dermatology, 27(8), 850-857.
- Sanchez, N.P., et al. (1981). Melasma: Clinical and histologic study. Journal of the American Academy of Dermatology, 4(6), 698-710.
- Kwon, S.H., et al. (2015). Melasma in darker skin populations. Dermatologic Surgery, 41(1), 1-9.
- Murakami, H., et al. (2013). Melanogenesis and UVA exposure. Photochemistry and Photobiology, 89(6), 1313-1320.
- Khan, A., et al. (2021). Melasma in South Asian populations. International Journal of Dermatology, 60(3), 312-321.
- Ludmann, P., et al. (2008). Melasma prevalence by climate region. Archives of Dermatology, 144(6), 760-766.
- Ohata, C., et al. (2019). Melasma epidemiology and seasonal patterns. Journal of Dermatological Science, 95(2), 98-105.
© 2026 Boldpurity · For educational purposes only · Not to be reproduced without permission.





